Diabetes Research and Clinical Practice
Volume 77, Issue 1 , Pages 120-125 , July 2007

HbA1c is outcome predictor in diabetic patients with sepsis

  • Ivan Gornik

      Affiliations

    • Division of Emergency and Intensive Care Medicine, Department of Medicine, Rebro University Hospital, Kispaticeva 12, Zagreb 10000, Croatia
    • Equal contribution.
    • Corresponding Author InformationCorresponding author. Tel.: +385 91 520 3222; fax: +385 1 2388 745.
    • ,
  • Olga Gornik

      Affiliations

    • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Kovaciceva 1, Zagreb 10000, Croatia
    • Equal contribution.
    • ,
  • Vladimir Gašparović

      Affiliations

    • Division of Emergency and Intensive Care Medicine, Department of Medicine, Rebro University Hospital, Kispaticeva 12, Zagreb 10000, Croatia

Received 18 July 2006 ,Accepted 17 October 2006.

References 

  1. Bertoni AG, Saydah S, Brancati FL. Diabetes and the risk of infection-related mortality in the US. Diab. Care. 2001;24:1044–1049
  2. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128:3233–3239
  3. Metan G, Zarakolu P, Cakir B, Hascelik G, Uzun O. Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int. J. Antimicrob. Agents. 2005;26:254–257
  4. Van den Berghe GH. Role of intravenous insulin therapy in critically ill patients. Endocr. Pract. 2004;10(Suppl. 2):17–20
  5. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J. Clin. Invest. 2004;114:1187–1195
  6. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 2004;32:858–873
  7. Rahbar S. The discovery of glycated hemoglobin. Ann. N. Y. Acad. Sci. 2005;1043:9–19
  8. Lapolla A, Traldi P, Fedele D. Importance of measuring products of non-enzymatic glycation of proteins. Clin. Biochem. 2005;38:103–115
  9. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15:16R–28R
  10. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diab. Care. 2003;26:3160–3167
  11. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 1998;15:539
  12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 International sepsis definition conference. Crit. Care Med. 2003;31:1250–1256
  13. On behalf of the working group on sepsis-related problems of the european society of intensive care medicine. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707–710
  14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit. Care Med. 1985;13:818–829
  15. Bessman AN, Sapico FL. Infections in the diabetic patient: the role of immune dysfunction and pathogen virulence factors. J. Diab. Complications. 1992;6:258–262
  16. Turina M, Fry DE, Polk HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit. Care Med. 2005;33:1624–1633
  17. Kjersem H, Hilsted J, Madsbad S, Wandall JH, Johansen KS, Borregaard N. Polymorphonuclear leucocyte dysfunction during short term metabolic changes from normo- to hyperglycemia in type 1 (insulin dependent) diabetic patients. Infection. 1988;16:215–221
  18. Alba-Loureiro TC, Hirabara SM, Mendonca JR, Curi R, Pithon-Curi TC. Diabetes causes marked changes in function and metabolism of rat neutrophils. J. Endocrinol. 2006;188:295–303
  19. Coban E, Bostan F, Ozdogan M. The mean platelet volume in subjects with impaired fasting glucose. Platelets. 2006;17:67–69
  20. Watala C, Golanski J, Pluta J, Boncler M, Rozalski M, Luzak B, et al. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control. Thromb. Res. 2004;113:101–113
  21. Rao AK, Chouhan V, Chen X, Sun L, Boden G. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes. 1999;48:1156–1161
  22. Stegenga ME, van der Crabben SN, Levi M, de Vos AF, Tanck MW, Sauerwein HP, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans. Diabetes. 2006;55:1807–1812
  23. Yan SF, Ramasamy R, Naka Y, Schmidt AM. Glycation, Inflammation, and RAGE: A Scaffold for the Macrovascular Complications of Diabetes and Beyond. Circ. Res. 2003;93:1159–1169
  24. Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH, et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diab. Care. 2003;26:2165–2173
  25. Tan KC, Chow WS, Tam S, Bucala R, Betteridge J. Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diab. Care. 2004;27:223–228
  26. Liliensiek B, Weigand MA, Bierhaus A, Nicklas W, Kasper M, Hofer S, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 2004;113:1641–1650
  27. Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V. A novel advanced glycation index and its association with diabetes and microangiopathy. Metabolism. 2005;54:1002–1007
  28. Schleicher ED, Wagner E, Nerlich AG. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 1997;99:457–468
  29. Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diab. Care. 1999;22:1543–1548
  30. Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y. Increased serum levels of advanced glycation end-products and diabetic complications. Diab. Res. Clin. Pract. 1998;41:131–137
  31. Furth AJ. Glycated proteins in diabetes. Br. J. Biomed. Sci. 1997;54:192–200
  32. Sharma C, Dalferes ER, Radhakrishnamurthy B, Rosen EL, Berenson GS. Nonenzymatic glycosylation of proteins and protease activities in granulation tissues in experimental diabetes. Inflammation. 1986;10:403–411
  33. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabet. Med. 2004;21:305–310

PII: S0168-8227(06)00488-8

doi: 10.1016/j.diabres.2006.10.017

Diabetes Research and Clinical Practice
Volume 77, Issue 1 , Pages 120-125 , July 2007

Article Tools

* Image Usage & Resolution